Diacrin s.r.o.

Research site

Slovakia Kosicka 43/d, 821 08 Ruzinov, Slovakia

Type 2 diabetes mellitus · Obesity · Chronic kidney disease
Adult patients

About Specializations

Diacrin s.r.o. in Ruzinov, Slovakia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Chronic kidney disease, Overweight, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Kosicka 43/d821 08 RuzinovSlovakia

Open in maps ↗

Recruiting now: no trials
Conditions studied: 4

More sites in Ruzinov Slovakia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Dulaglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Canagliflozin
Sponsor:Eli Lilly & Co.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites